Biotech Position Answers and News

Biotech Position Questions and Answers

Biotech Position News

MannKind Elects James S. Shannon to its Board of Directors - Earthtimes

Shannon held a number of significant positions in Novartis including Head of the Integration Office for R&D overseeing the creation of the Novartis R&D groups from those of Ciba and Sandoz and also Head of the Cardiovascular Strategic Team.

Intel leads $3.5B investment to fuel tech job growth - EDN.com

To support investment in US-based growth-oriented industries Intel President and CEO Paul Otellini said Tuesday during a speech at The Brookings Institution in Washington, DC, a $3.5 billion initiative along with a commitment to increase the number ...

Invest in America Alliance to Fund American Technology Companies ... - WebWire

* Intel Capital leads venture capital industry commitment to invest $3.5 billion in U.S. companies. * Pledge by 17 corporations to increase hiring goals in 2010 resulting in 10,500 new jobs for college graduates. * Invest in America Alliance unveiled ...

Tech firms launch their own ‘economic stimulus’ plan, pledge $3.5 ... - SmartPlanet.com

The economic stimulus package launched by the US government last year may help create jobs and opportunities in shovel-ready areas such as construction and infrastructure, but Silicon Valley felt it needed an additional boost. Now, some leading tech ...

House Speaker William Murphy leaves a mixed legacy - Providence Journal

I took a look at the list of accomplishments put out by former House Speaker William Murphy when he stepped down 10 days ago after serving eight years as one of the most powerful politicians in Rhode Island. His list includes holding the line on ...

iPierian names new president and chief scientific officer - TMCnet

Feb 24, 2010 (Datamonitor via COMTEX) -- iPierian, a biopharmaceutical company, has appointed Michael Venuti as its new president and chief scientific officer. Prior to joining iPierian, Dr Venuti served as CEO and member of the board of directors of ...

Intel leads US$3.5bn venture and graduate push in US - Silicon Republic

Chip giant Intel is to drive a US$3.5-billion venture capital initiative to grow US industries in a move that will also increase jobs that will be available to college graduates. Intel CEO and chairman Paul Otellini announced these initiatives in a ...

StockExploder.com Is Going To Help Your Portfolio!! Sign Up Today ... - TMCnet

(M2 PressWIRE Via Acquire Media NewsEdge) StockExploder PRESENTS :(OTCBB: BLGW) ("Bloggerwave") (OTCBB: PEPR - Pepper Rock Resources Corp.) ,(OTCBB: RCYT - Recycle Technology, Inc.) Vencor International, Inc. (PINKSHEETS: VCOR),Vicor Technologies ...

Bt Brinjal moratorium to stay: Ramesh - The Gaea Times

Biocon's Mazumdar-Shaw backs Bt brinjal cultivation January 19th, 2010 BANGALORE - India's biotech "queen" Kiran Mazumdar-Shaw of Biocon Tuesday appealed for considering the issue of Bt brinjal cultivation on a scientific basis and not on "unfounded ...

Intel, VC Firms to Make $3.5 Billion in Investments - Smart Money

Most of the jobs will largely be for those with engineering and computer science backgrounds, but other positions will also be made available in financial analysis, marketing, management consulting, sales and other business areas. At Intel, the hires ...

Can Intel Do Better Than Uncle Sam?

I have never loved Intel the way I do right now. A blazing 30-minute speech delivered by CEO Paul Otellini yesterday served many purposes, all of them admirable: Outline the roots of America's declining focus on innovation. more

10 Stocks Shaking the Market

Some stocks are one-hit wonders, making a big splash when they first appear, then quickly fizzling into obscurity or oblivion. more

Build Your Fortune With These Winners

The Oracle of Omaha, Warren Buffett, turned an initial bankroll of $10,000 into a multibillion-dollar conglomerate.A Shelby Davis began with $50,000, and he amassed a $900 million fortune. more

Top 500 OC Co's

Do not hesitate to call us with any questions at 1 549-4180. more

Is Ben Bernanke Smart Enough to Be a CEO?

Ben Bernanke has got to be laughing it up after being reappointed to another term as Federal Reserve chairman . more

Top executive resigns from Alico, successor named

Investment bank Broadpoint Gleacher Securities Group Inc. said Monday its chief executive has stepped down to pursue other interests. more

J&J's Dilemma: Marketing New Drugs Without Cannibalizing Its Lead Product

Remicade , a biologic drug for the treatment of rheumatoid arthritis and other autoimmune diseases, remains the top growth driver for Johnson & Johnson . more

New Market Report: Pipeline Insight: Biologic Targeted Cancer...

New Market Report: Pipeline Insight: Biologic Targeted Cancer Therapies - Next generation jostles for market position 2010-02-23 18:09:24 - New Pharmaceuticals research report from Datamonitor is now available from Fast Market Research Biologic molecular targeted therapies have driven much of the recent high growth in the oncology market and ... more

Arzeda CEO Resigns; Company Looks to Prove Technology, Conserve Cash

Arzeda CEO Michael Martino is out. Martino, the former CEO of Bothell, WA-based Sonus Pharmaceuticals, has resigned his job as CEO of the Seattle designer-enzyme startup, and plans to take a new position with a biotech company in San Diego, according to an e-mail he sent today to friends and colleagues. more

Genocea Biosciences Licenses Extensive Herpes Simplex Virus Patent...

Genocea Biosciences, a leading vaccine discovery and development company, today announced that it has licensed an extensive patent estate from the University of Washington and the Fred Hutchinson Cancer Research Center for 25 pending and issued patents related to herpes simplex virus type 2 antigens. more

Search Failed

Sorry, the connection to the search server either timed out or is unavailable, please try your search again. more

Welcome to Biotech Position